355 related articles for article (PubMed ID: 12519922)
1. Community-based therapy for multidrug-resistant tuberculosis in Lima, Peru.
Mitnick C; Bayona J; Palacios E; Shin S; Furin J; Alcántara F; Sánchez E; Sarria M; Becerra M; Fawzi MC; Kapiga S; Neuberg D; Maguire JH; Kim JY; Farmer P
N Engl J Med; 2003 Jan; 348(2):119-28. PubMed ID: 12519922
[TBL] [Abstract][Full Text] [Related]
2. Identifying early treatment failure on category I therapy for pulmonary tuberculosis in Lima Ciudad, Peru.
Chavez Pachas AM; Blank R; Smith Fawzi MC; Bayona J; Becerra MC; Mitnick CD
Int J Tuberc Lung Dis; 2004 Jan; 8(1):52-8. PubMed ID: 14974746
[TBL] [Abstract][Full Text] [Related]
3. Using treatment failure under effective directly observed short-course chemotherapy programs to identify patients with multidrug-resistant tuberculosis.
Becerra MC; Freeman J; Bayona J; Shin SS; Kim JY; Furin JJ; Werner B; Sloutsky A; Timperi R; Wilson ME; Pagano M; Farmer PE
Int J Tuberc Lung Dis; 2000 Feb; 4(2):108-14. PubMed ID: 10694087
[TBL] [Abstract][Full Text] [Related]
4. The treatment of multidrug-resistant tuberculosis in Turkey.
Tahaoğlu K; Törün T; Sevim T; Ataç G; Kir A; Karasulu L; Ozmen I; Kapakli N
N Engl J Med; 2001 Jul; 345(3):170-4. PubMed ID: 11463011
[TBL] [Abstract][Full Text] [Related]
5. Occurrence of serious adverse effects in patients receiving community-based therapy for multidrug-resistant tuberculosis.
Furin JJ; Mitnick CD; Shin SS; Bayona J; Becerra MC; Singler JM; Alcantara F; Castañieda C; Sanchez E; Acha J; Farmer PE; Kim JY
Int J Tuberc Lung Dis; 2001 Jul; 5(7):648-55. PubMed ID: 11467371
[TBL] [Abstract][Full Text] [Related]
6. Treatment outcomes for HIV-uninfected patients with multidrug-resistant and extensively drug-resistant tuberculosis.
Kwon YS; Kim YH; Suh GY; Chung MP; Kim H; Kwon OJ; Choi YS; Kim K; Kim J; Shim YM; Koh WJ
Clin Infect Dis; 2008 Aug; 47(4):496-502. PubMed ID: 18611154
[TBL] [Abstract][Full Text] [Related]
7. [Characteristics and treatment outcomes of INH-resistant or RFP-resistant tuberculosis].
Saito W; Nagayama N; Miyamoto M; Hara H; Suzuki J; Masuda K; Baba M; Tamura A; Nagai H; Akagawa S; Kawabe Y; Machida K; Kurashima A; Yotsumoto H
Kekkaku; 2003 Oct; 78(10):611-7. PubMed ID: 14621568
[TBL] [Abstract][Full Text] [Related]
8. Community-based therapy for children with multidrug-resistant tuberculosis.
Drobac PC; Mukherjee JS; Joseph JK; Mitnick C; Furin JJ; del Castillo H; Shin SS; Becerra MC
Pediatrics; 2006 Jun; 117(6):2022-9. PubMed ID: 16740844
[TBL] [Abstract][Full Text] [Related]
9. Self-administered, standardized regimens for multidrug-resistant tuberculosis in South Korea.
Park SK; Lee WC; Lee DH; Mitnick CD; Han L; Seung KJ
Int J Tuberc Lung Dis; 2004 Mar; 8(3):361-8. PubMed ID: 15139476
[TBL] [Abstract][Full Text] [Related]
10. Tuberculosis susceptibility patterns, predictors of multidrug resistance, and implications for initial therapeutic regimens at a New York City hospital.
Weltman AC; Rose DN
Arch Intern Med; 1994 Oct; 154(19):2161-7. PubMed ID: 7944836
[TBL] [Abstract][Full Text] [Related]
11. Treatment of multidrug-resistant tuberculosis in San Francisco: an outpatient-based approach.
Burgos M; Gonzalez LC; Paz EA; Gournis E; Kawamura LM; Schecter G; Hopewell PC; Daley CL
Clin Infect Dis; 2005 Apr; 40(7):968-75. PubMed ID: 15824988
[TBL] [Abstract][Full Text] [Related]
12. Community-based treatment of multidrug-resistant tuberculosis in Lima, Peru: 7 years of experience.
Shin S; Furin J; Bayona J; Mate K; Kim JY; Farmer P
Soc Sci Med; 2004 Oct; 59(7):1529-39. PubMed ID: 15246180
[TBL] [Abstract][Full Text] [Related]
13. Bacteriologic monitoring of multidrug-resistant tuberculosis patients in five DOTS-Plus pilot projects.
Gammino VM; Taylor AB; Rich ML; Bayona J; Becerra MC; Bonilla C; Gelmanova I; Hollo V; Jaramillo E; Keshavjee S; Leimane V; Mitnick CD; Quelapio MI; Riektsina V; Tupasi TE; Wells CD; Zignol M; Cegielski PJ
Int J Tuberc Lung Dis; 2011 Oct; 15(10):1315-22. PubMed ID: 22283887
[TBL] [Abstract][Full Text] [Related]
14. Pulmonary resection combined with isoniazid- and rifampin-based drug therapy for patients with multidrug-resistant and extensively drug-resistant tuberculosis.
Park SK; Kim JH; Kang H; Cho JS; Smego RA
Int J Infect Dis; 2009 Mar; 13(2):170-5. PubMed ID: 18768342
[TBL] [Abstract][Full Text] [Related]
15. Ambulatory treatment of multidrug-resistant pulmonary tuberculosis patients at a chest clinic.
Kim HJ; Hong YP; Kim SJ; Lew WJ; Lee EG
Int J Tuberc Lung Dis; 2001 Dec; 5(12):1129-36. PubMed ID: 11769771
[TBL] [Abstract][Full Text] [Related]
16. [Treatment outcomes of multidrug-resistant tuberculosis--comparison between success and failure cases].
Shigetoh E; Murakami I; Yokosaki Y; Kurimoto N
Kekkaku; 2001 Dec; 76(12):723-8. PubMed ID: 11806128
[TBL] [Abstract][Full Text] [Related]
17. HIV-positive patients treated for multidrug-resistant tuberculosis: clinical outcomes in the HAART era.
Palacios E; Franke M; Muñoz M; Hurtado R; Dallman R; Chalco K; Guerra D; Mestanza L; Llaro K; Bonilla C; Sebastian J; Bayona J; Lygizos M; Anger H; Shin S
Int J Tuberc Lung Dis; 2012; 16(3):348-54. PubMed ID: 22640448
[TBL] [Abstract][Full Text] [Related]
18. Drug resistance profiles of Mycobacterium tuberculosis isolates: five years' experience and insight into treatment strategies for MDR-TB in Lima, Peru.
Timperi R; Han LL; Sloutsky A; Becerra MC; Nardell EA; Salazar JJ; Smith-Fawzi MC
Int J Tuberc Lung Dis; 2005 Feb; 9(2):175-80. PubMed ID: 15732737
[TBL] [Abstract][Full Text] [Related]
19. Multidrug-resistant tuberculosis in patients without HIV infection.
Telzak EE; Sepkowitz K; Alpert P; Mannheimer S; Medard F; el-Sadr W; Blum S; Gagliardi A; Salomon N; Turett G
N Engl J Med; 1995 Oct; 333(14):907-11. PubMed ID: 7666876
[TBL] [Abstract][Full Text] [Related]
20. Treatment of isoniazid-resistant tuberculosis with isoniazid, rifampin, ethambutol, and pyrazinamide for 6 months.
Nolan CM; Goldberg SV
Int J Tuberc Lung Dis; 2002 Nov; 6(11):952-8. PubMed ID: 12475140
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
